DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Roccaro AM, Sacco A, Jimenez C. et al.
C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma.
Blood 2014;
123 (26) 4120-4131
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.